Rare Discussions

Rare Discussions

By CheckRare EditorsMedicineHealth & Fitness
Download on the App Store

Rare Discussions episodes

  • Mucopolysaccharidoses (MPSs) Research Highlights
    Barbara K. Burton, MD from the Northwestern University Feinberg School of Medicine
    Chicago, IL provides an overview of Mucopolysaccharidoses (MPSs) Highlights from WORLDSymposium.

    This CME activity is possible through an educational grant from Ultragenyx Pharmaceutical Inc

    To obtain credit for this activity, please visit https://checkrare.com/learning/p-2020world-mps-highlights-from-worldsymposium-2020/

    Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

    Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

    Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

    Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.


    20 min
  • When to Suspect ATTR Amyloidosis
    Morie A Gertz, MD, MACP, Professor of Medicine at the Mayo Clinic College of Medicine and Science in Rochester, Minnesota discusses signs and symptoms that are suspicious of ATTR amyloidosis.

    This CME activity is possible through an educational grants from Akcea Therapeutics and Alnylam Pharmaceuticals.

    To obtain credit for this activity, please visit https://checkrare.com/learning/p-managing-attr-module1-suspecting-attr-amyloidosis/

    Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

    Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

    Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

    Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.


    19 min
  • Diagnosing ATTR Amyloidosis
    Morie A Gertz, MD, MACP, Professor of Medicine at the Mayo Clinic College of Medicine and Science in Rochester, Minnesota discusses best practices to diagnose ATTR amyloidosis.

    This CME activity is possible through an educational grants from Akcea Therapeutics and Alnylam Pharmaceuticals.

    To obtain credit for this activity, please visit https://checkrare.com/learning/p-managing-attr-module2-diagnosing-attr-amyloidosis/

    Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

    Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

    Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

    Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.


    16 min
  • Spinal Muscular Atrophy and Genetic Counseling
    Nancy L. Kuntz, MD, FAAN, Professor of Pediatrics and Neurology at Northwestern University Feinberg School of Medicine provides an overview of the importance of genetic counseling for spinal muscular atrophy (SMA).

    This CME activity is possible through an educational grant from AveXis.

    To obtain credit for this activity, please visit https://checkrare.com/learning/p-spinal-muscular-atrophy-module4-genetic-counseling-sma/

    Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

    Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

    Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

    Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.


    13 min
  • Spinal Muscular Atrophy and Newborn Screening
    Nancy L. Kuntz, MD, FAAN, Professor of Pediatrics and Neurology at Northwestern University Feinberg School of Medicine provides an overview of the importance of newborn screening for spinal muscular atrophy (SMA).

    This CME activity is possible through an educational grant from AveXis.

    To obtain credit for this activity, please visit https://checkrare.com/learning/p-spinal-muscular-atrophy-module3-newborn-screening-sma/

    Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

    Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

    Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

    Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.


    13 min
  • Treating Spinal Muscular Atrophy
    Nancy L. Kuntz, MD, FAAN, Professor of Pediatrics and Neurology at Northwestern University Feinberg School of Medicine provides an overview of best practices to treat spinal muscular atrophy (SMA).

    This CME activity is possible through an educational grant from AveXis.

    To obtain credit for this activity, please visit https://checkrare.com/learning/p-spinal-muscular-atrophy-module2-managing-sma/

    Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

    Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

    Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

    Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.


    15 min
  • Diagnosing Spinal Muscular Atrophy
    Nancy L. Kuntz, MD, FAAN, Professor of Pediatrics and Neurology at Northwestern University Feinberg School of Medicine provides an overview of best practices to diagnose spinal muscular atrophy (SMA).

    This CME activity is possible through an educational grant from AveXis.

    To obtain credit for this activity, please visit https://checkrare.com/learning/p-spinal-muscular-atrophy-module1-diagnosing-sma/

    Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

    Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

    Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

    Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.


    15 min
  • NETS Research Highlights
    Edward M Wolin, MD, Professor of Medicine from the Icahn School of Medicine at Mount Sinai provides an overview of neuroendocrine tumors research highlights presented at ENDO 2020.

    This CME activity is possible through an educational grant from Ipsen BioPharmaceuticals, Inc.

    To obtain credit for this activity, please visit https://checkrare.com/learning/p-endo2020-neuroendocrine-tumors-nets-abstract-highlights/

    Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

    Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

    Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

    Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.


    13 min
  • Rolling Submission for Cilta-cel to Treat Relapsed/Refractory Multiple Myeloma
    Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

    Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

    Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

    Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.


    6 min
  • Clinical Data Shows Promise for SCID Treatment
    Judy Shizuru, MD, Blood and Marrow Transplant Specialist, Stanford University School of Medicine, discusses clinical data from an ongoing phase 1 trial of JSP191 in patients with severe combined immune deficiency (SCID).

    SCID is a group of inherited immune system disorders characterized by abnormalities with responses of both T cells and B cells. Common symptoms include an increased susceptibility to infections including ear infections; pneumonia or bronchitis; oral thrush; and diarrhea.
    As Dr. Shizuru explains, JSP191 is a humanized monoclonal antibody in clinical development as a conditioning agent that clears hematopoietic stem cells from bone marrow.

    Preclinical studies have shown that JSP191 as a single agent safely decreases normal and diseased hematopoietic stem cells, including in animal models of SCID, myelodysplastic syndromes (MDS) and sickle cell disease (SCD). JSP191 is currently being evaluated as a sole conditioning agent in a phase 1/2 trial evaluating the safety and tolerability of JSP191 in patients undergoing hematopoietic cell transplant for SCID. JSP191 is also being evaluated in a phase 1 study in patients with MDS or acute myeloid leukemia (AML) who are receiving hematopoietic cell transplant.

    To learn more about SCID and other rare autoimmune disorders, visit https://checkrare.com/diseases/autoimmune-auto-inflammatory-disorders/

    Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

    Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

    Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

    Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.


    6 min

About Rare Discussions

From the publisher's feed

Conversations with the leaders advancing rare disease care.  

Rare Discussions is CheckRare's flagship interview podcast featuring conversations with leading physicians, researchers,…